Leighton shares his journey at Qkine
In our latest career blog our Senior Cell Scientist Leighton shares his experience and journey at Qkine.
28
11, 2024
15
11, 2024
CARMA panel discussion: How can we best transform academic innovation into scalable industrial processes? Part 3
This blog focuses academic-industrial relationships, what academic laboratories can learn from industrial experts. Read the other blogs for more insights.
15
11, 2024
CARMA panel discussion: How can we best transform academic innovation into scalable industrial processes? Part 2
This blog focuses Importance of cell and growth factor selection and how this can affect the future regulatory approval and future commercialization of academic research. Read the other blogs for more insights.
15
11, 2024
CARMA panel discussion: How can we best transform academic innovation into scalable industrial processes? Part 1
The panel discussion offered perspectives from companies working to bring cultivated meat, fish, fat and dairy to consumers. The aim was to inspire early career researchers and demystify research in this industry to highlight and encourage transitions in both directions between academia and industry. This blog focuses on the current regulatory frameworks and how the future of regulation may impact both industry and the future commercialization of academic research. Read the follow up blogs for more insights.
25
10, 2024
Qkine featured in the Nikkei Biotechnology & Business magazine
Qkine are delighted that our eel FGF-2 proteins have elicited interest in Japan, recently the Nikkei Biotechnology & Business magazine have published an article focussing on the 145 and 154 amino acid versions of eel FGF-2, and the contribution Qkine species specific growth factors can have on the cultured seafood industry.
24
10, 2024
National Alternative Protein Innovation Centre (NAPIC) launched
NAPIC is a £38m centre dedicated to developing acceptable and planet-friendly alternatives to animal proteins led by researchers from the University of Leeds, James Hutton Institute, University of Sheffield and Imperial College London.
4
10, 2024
Qkine integrates the latest advancement in fill-finish automation into its recombinant protein manufacturing process
Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.
12
09, 2024
Qkine collaboration with the Bertero Lab, Heart Engineering and Developmental Genomics et al. (HEDGe), University of Turin, Italy
This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.
30
08, 2024
The transformative power of hematopoietic stem cells in medicine
Hematopoietic stem cells (HSCs) are at the forefront of a transformative shift in modern medicine, beginning to revolutionize patient care by offering novel therapeutic treatments for a wide range of diseases. This review blog summarizes advances in the clinical use of HSCs in HSC transplantation.
14
08, 2024
ISSCR 2024: scientists and suppliers working together will improve the future of stem cell research
Qkine is a company run by scientists, and the science is the focus of everything we do.Our theme at ISSCR this year was stress-free stem cell culture - exploring how suppliers of recombinant proteins can proactively improve the quality, availability and functionality of growth factors to generate experimental outcomes faster, easier and more efficiently.We discussed priorities for the stem cell science supply chain with scientists from academic and industry labs and had in-depth conversations about the impact of growth factors and cytokines quality on reproducibility and how to integrate new technologies, such as controlled-release and thermostable proteins, to improve the scalability of expansion and differentiation protocols.Through collaboration, we learn and, together, improve the future of stem cell research.
